Physician Education for Fistula Treatment Act
HB9015, titled the Physician Education for Fistula Treatment Act, would authorize U.S. assistance to help train and retain obstetrician-gynecologists and urogynecology specialists in least developed countries. The bill frames obstetric fistula and related childbirth injuries as preventable, severe maternal health harms that disproportionately affect impoverished and marginalized women and girls, and it ties the issue to broader goals of maternal health, human rights, and health-system strengthening.
The legislation directs the President, acting through the Fogarty International Center at NIH, to support an International OB/GYN and Urogynecology Promotion Program. That program could fund fellowship and residency training, training centers, partnerships with universities and clinical institutions, and other efforts to expand local expertise in women’s health care, childbirth injury prevention, treatment, and rehabilitation. It also requires a comprehensive 10-year strategy to address physician shortages in least developed countries and annual reporting to Congress on implementation and program effectiveness.
If enacted, the bill would create a new federal foreign assistance program focused on maternal health workforce development and obstetric fistula prevention and treatment in least developed countries. It would not directly amend domestic state law, but it would expand federal international health authority and assign implementation responsibilities to the Fogarty International Center, with coordination across relevant executive agencies such as the State Department and USAID. The bill would also require a long-term strategy and recurring reports to Congress, potentially shaping future appropriations and foreign health programming.
Based on the bill text and the absence of recorded committee debate or votes in the provided context, the overall sentiment appears strongly supportive and humanitarian. The findings section uses urgent and rights-based language, emphasizing the preventability of obstetric fistula, the suffering of affected women and girls, and the need for intensified international action. There is no evidence in the provided record of organized opposition, amendments, or divided voting.
No specific points of contention are reflected in the provided transcripts or voting history, because none were supplied. Potential areas of debate, based on the bill’s structure, could include whether the United States should fund international medical training programs, whether the Fogarty International Center is the appropriate implementing entity, and how resources should be prioritized among prevention, treatment, and capacity-building efforts. However, those issues are not shown as disputed in the available record.